Define the relevant geography, services, patients, and decision before counting competitors. Use dated public evidence, appropriate demographic data, and lawfully reviewed aggregate practice information to assess alternatives, access, positioning, and capacity. Distinguish observed facts from estimates. A map of clinics is not market share, and a wealthy population does not by itself prove demand for the acquired practice.

What acquisition question should the study answer?

Identify whether the buyer is testing existing demand, pricing pressure, a new service, expansion, referral dependence, or a downside case. A general map can organize information, but the useful study links evidence to a specific operating assumption in the acquisition model.

A catchment is the defined area from which the practice draws or expects to draw relevant demand under stated assumptions. It is an analytical boundary rather than proof that all residents are potential patients or that everyone outside it is irrelevant.

State the services, geography, period, and population being considered. A short-visit routine service and a specialized treatment may have different travel patterns. Avoid applying one arbitrary radius to the entire menu without examining access and the practice’s actual relationships.

How should the geographic boundary be chosen?

Consider travel time, roads, transit where relevant, work patterns, parking, physical barriers, nearby employment, and existing patient-origin patterns under an appropriate privacy process. A circle can include difficult-to-reach areas while excluding convenient routes.

Use more than one reasonable boundary when the evidence is uncertain. Explain why the alternatives matter and what would change in the conclusion. Sensitivity is more useful than presenting a precise catchment as established when it is only an assumption.

Separate existing demand from expansion aspirations. A seller may describe a broad regional reputation while most observed visits come from nearby areas. Neither statement should be accepted or rejected without evidence; define what the available data actually show.

Which businesses belong in the competitor set?

SBA’s planning and competitive-analysis guidance encourages examining competition by product or service and market segment, including indirect alternatives. Apply that logic to the actual aesthetic services rather than counting every salon, spa, clinic, or wellness brand as equivalent.

Classify direct service alternatives, partial substitutes, adjacent providers, and businesses whose relevance is unclear. Review location, public service menu, professional information where appropriately available, booking access, published price structure, and positioning. Record the source and date.

Do not infer quality, compliance, revenue, or capacity from appearance alone. A polished website can coexist with limited availability, while a modest site may represent a well-established practice. The study should distinguish public claims and observations from conclusions requiring further evidence.

How can demographic data be used responsibly?

The Census Bureau’s Business Builder provides selected demographic and economic information and geographic comparison tools. Record the specific geography, dataset, period, definition, and limitations behind any figure used. The tool’s availability does not establish the demand for a particular procedure or practice.

Age, population, income, employment, and other context can help frame questions. They should not be converted automatically into treatment eligibility, purchase intent, spending, or market share. Residents differ, and the clinical and commercial pathway from population to actual care requires its own evidence.

Check geography and period consistency. A county average may not describe a neighborhood, and a dated estimate may not reflect a recent development. Explain uncertainty and avoid presenting demographic precision as proof of an equally precise revenue forecast.

What should the competitor evidence ledger include?

Local competitive evidence fields
FieldSource or observationLimit
Identity and locationOfficial public informationMay need current confirmation
Relevant servicesPublished menu and authorized inquiryOffering does not prove volume
Price descriptionDated public termsBundles and consultation can differ
AccessPublic scheduling informationSnapshot is not full capacity
PositioningActual claims and audienceMarketing is not verified performance
Evidence confidenceSource, date, and open questionsUnknown remains unknown

Use transparent, appropriate research methods and respect platform and legal requirements. Do not obtain private patient records or impersonate a patient to manufacture privileged information. The buyer needs a defensible business study, not access to competitors’ confidential operations.

Why is clinic count not market share?

One site can have several providers and extensive hours, while another offers a narrow service on limited days. Brands may operate several locations, and locations may overlap. Counting storefronts does not establish revenue, visits, contribution, or patient relationships.

An invented example with eight listed clinics in a defined area does not imply the target owns one-eighth of the market. The denominator is a business count, not measured demand or sales. Keep any estimated share separate and identify the evidence and assumptions that would support it.

Similarly, review count or online visibility is not a reliable standalone measure of revenue. It can reflect age, platform behavior, incentives, or marketing. Use these observations as questions to test rather than converting them directly into market size or clinical reputation conclusions.

How can the target’s own patient information help?

Appropriately protected aggregate origin, service use, repeat behavior, referrals, and scheduling can show where actual demand comes from and how it behaves. Define the period, active population, observation window, and exclusions so the buyer can understand the analysis.

HHS’s Privacy Rule summary explains the framework for covered information uses and disclosures. Have privacy counsel determine the appropriate access, aggregation, de-identification where used, and transaction disclosure process. Removing a name informally does not settle every privacy obligation.

Do not upload identifiable patient lists to broad mapping or marketing tools without appropriate review. The study can often use coarse, aggregated evidence for preliminary questions. Match precision and access to the actual need rather than collecting the maximum detail available.

How should pricing and positioning be compared?

Compare like services, units, terms, bundles, professional resources, included evaluation, follow-up, and discounts where the evidence permits. A headline advertised price may exclude details or concern a different treatment. State what is publicly known and what remains incomparable.

Review whether the target competes on access, relationships, service breadth, location, professional capabilities, price, or another supported factor. Avoid claiming differentiation simply because the seller uses a slogan. Ask what observed patient behavior or operating evidence supports the distinction.

Do not recommend underpricing or service changes without testing costs, clinical requirements, and the buyer’s plan. A local competitor’s advertised offer does not establish a sustainable price for the target. The acquisition case should preserve lawful care and supportable economics.

How does the study enter a downside or growth case?

Translate findings into specific assumptions about demand, realized price, retention, capacity, acquisition cost, or investment. Keep actual observations separate from the inference. If a new competitor is only proposed, distinguish planned entry from confirmed operation.

Test reasonable alternatives rather than projecting one exact local outcome. Additional supply can affect services differently, and a strong target may respond through several operating choices. State which choices are supported and what resources they require.

Use the market hub, benchmark-reading guide, patient-acquisition metrics guide, and Four-Number Med Spa Valuation Screen. A local study becomes useful when it changes a testable business assumption.

What should the final study communicate?

  1. Define the decision, services, and catchment.
  2. Build a dated public evidence ledger.
  3. Use appropriate demographic context.
  4. Review target data with privacy safeguards.
  5. Separate observations from capacity and share estimates.
  6. Test operating assumptions and record limits.

State the date, sources, methods, missing information, and review triggers. A study prepared before a new location, major staffing change, or service launch may need refreshing. Do not call it a comprehensive market census unless the evidence and method support that claim.

Keep the working ledger so another reviewer can challenge or update the conclusion. A useful acquisition study explains where the buyer has evidence, where it has a plausible hypothesis, and which uncertainty still matters to price, funding, or the operating plan.

What else do owners and buyers ask?

What radius should I use for a med spa competition study?

There is no universal radius. Consider services, travel time, access, geography, work patterns, and appropriately reviewed patient-origin evidence. Test reasonable alternatives when uncertain and explain the boundary. A convenient circle should not be presented as proof of where all relevant patients live or how they choose care.

Can I estimate market share by counting local clinics?

Clinic count is a different denominator from revenue, visits, capacity, or patient demand. Sites vary in providers, hours, services, and scale. Use counts as one observation and label any additional estimate with its evidence and assumptions. Do not imply equal shares simply because several businesses appear on a map.

Does high local income prove demand for aesthetic services?

No. Demographic data provide context, not a direct measure of treatment eligibility, willingness to buy, access, frequency, or the target’s revenue. Record the source, geography, and period, then test company-specific patient behavior and the actual operating case. A forecast requires separate transparent assumptions and evidence.

Should I map individual patients to study the catchment?

Use only an appropriately reviewed process with necessary permissions and safeguards. Preliminary questions may be answerable with coarse aggregate information. Have privacy counsel assess applicable requirements before sharing data or using external tools. The buyer’s interest in geography does not create unrestricted rights to disclose identifiable patient relationships.

Which sources support this guide?

Sources were checked during research. Regulations, lender policies, and market conditions can change. Use the linked primary material and your advisors to confirm applicability.

  1. Plan your business: market research and competitive analysis — U.S. Small Business Administration
  2. Census Business Builder — U.S. Census Bureau
  3. Summary of the HIPAA Privacy Rule — HHS Office for Civil Rights

Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.